Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Substituting Hydromorphone for Morphine in Medical Aid in Dying: Clinical and Practice Implications.

Created on 26 Oct 2026

Authors

Kerri L Mason, Laura J Podewils, Samantha J Stein, Jeremy A Long

Published in

Journal of palliative medicine. Pages 10966218261501610. Oct 25, 2026. Epub Oct 25, 2026.

Abstract

A morphine shortage in 2024-2025 led Medical Aid in Dying (MAiD) prescribers to substitute hydromorphone for morphine.
To evaluate associations between substitution and time to death and sleep among patients supported by Denver Health's MAiD program, which serves Colorado.
Quasi-experimental pre-post study of patients between January 2024 and February 2026 with verified ingestion, time to sleep, and time to death.
Kaplan-Meier and Cox proportional hazards models compared time to death and sleep.
Among 83 patients, median time to death did not differ between hydromorphone and morphine (55 vs. 65.5 minutes; p = 0.29). Median time to sleep was shorter with hydromorphone (3 vs. 5.5 minutes; p = 0.0007). After adjusting for age, hydromorphone was associated with a twofold faster time to sleep (adjusted hazard ratio 2.08, 95% CI: 1.29-3.36).
Hydromorphone was associated with shorter time to sleep than morphine, with no significant difference in time to death. Further study should assess its use as an alternative to morphine.

PMID:
42927983
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement